Sodium-glucose cotransporter type 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies

被引：0
作者：
Tomasoni, Daniela
Stretti, Lorenzo
Adamo, Marianna
Metra, Marco
机构：
[1] Univ Brescia, Dipartimento Cardiotorac, UO Cardiol, ASST Spedali Civili Brescia, Brescia, Italy
[2] Univ Brescia, Dipartimento Specialita Med Chirurg Sci Radiol &, Brescia, Italy
来源：
GIORNALE ITALIANO DI CARDIOLOGIA | 2023年 / 24卷 / 04期
关键词：
CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 254
页数：4
相关论文
共 52 条
  • [1] Akinci B, 2019, NEW ENGL J MED, V380, P1881, DOI 10.1056/NEJMc1902837
  • [2] Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions
    Anker, Stefan D.
    Siddiqi, Tariq Jamal
    Filippatos, Gerasimos
    Zannad, Faiez
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Brueckmann, Martina
    Zeller, Cordula
    Packer, Milton
    Butler, Javed
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (08) : 1400 - 1405
  • [3] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1451 - 1461
  • [4] Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Shahzeb Khan, Muhammad
    Pedro Ferreira, Joao
    Bocchi, Edimar
    Bohm, Michael
    Pieter Brunner-La Rocca, Hans
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio, V
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Seronde, Marie-France
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2383 - 2392
  • [5] Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos S.
    Jamal, Waheed
    Salsali, Afshin
    Schnee, Janet
    Kimura, Karen
    Zeller, Cordula
    George, Jyothis
    Brueckmann, Martina
    Zannad, Faiez
    Packer, Milton
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos S.
    Zannad, Faiez
    George, Jyothis
    Brueckmann, Martina
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (10) : 1279 - 1287
  • [6] Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines
    Bayes-Genis, Antoni
    Aimo, Alberto
    Metra, Marco
    Anker, Stefan
    Seferovic, Petar
    Rapezzi, Claudio
    Castiglione, Vincenzo
    Nunez, Julio
    Emdin, Michele
    Rosano, Giuseppe
    Coats, Andrew J. S.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (06) : 916 - 926
  • [7] Prevention of heart failure events with sodium-glucose co-transporter 2 inhibitors across a spectrum of cardio-renal-metabolic risk
    Bhatia, Kirtipal
    Jain, Vardhmaan
    Gupta, Kartik
    Bansal, Agam
    Fox, Arieh
    Qamar, Arman
    Damman, Kevin
    Vaduganathan, Muthiah
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (06) : 1002 - 1008
  • [8] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Bhatt, Deepak L.
    Szarek, Michael
    Pitt, Bertram
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Cherney, David Z. I.
    Dwyer, Jamie P.
    Scirica, Benjamin M.
    Bailey, Clifford J.
    Diaz, Rafael
    Ray, Kausik K.
    Udell, Jacob A.
    Lopes, Renato D.
    Lapuerta, Pablo
    Steg, P. Gabriel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) : 129 - 139
  • [9] Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
    Biegus, Jan
    Voors, Adriaan A.
    Collins, Sean P.
    Kosiborod, Mikhail N.
    Teerlink, John R.
    Angermann, Christiane E.
    Tromp, Jasper
    Ferreira, Joao Pedro
    Nassif, Michael E.
    Psotka, Mitchell A.
    Brueckmann, Martina
    Salsali, Afshin
    Blatchford, Jonathan P.
    Ponikowski, Piotr
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (01) : 41 - +
  • [10] Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
    Boorsma, Eva M.
    Beusekamp, Joost C.
    ter Maaten, Jozine M.
    Figarska, Sylwia M.
    Danser, A. H. Jan
    van Veldhuisen, Dirk J.
    van Der Meer, Peter
    Heerspink, Hiddo J. L.
    Damman, Kevin
    Voors, Adriaan A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (01) : 68 - 78
123456